Clonazepam Tablets Recalled Due to Carton Labeling Error
Endo Pharmaceuticals is recalling 8,139 cartons of Clonazepam Orally Disintegrating Tablets due to carton labeling errors. The carton labels incorrectly state 0.125 mg while the actual tablets inside contain 0.25 mg.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class I, which per the rubric requires a minimum severity score of 4. Although no illnesses or injuries have been reported, the labeling error creates potential for medication dosing errors when providers or patients base decisions on the incorrect carton label rather than the actual tablet strength.
Plain-English summary
Endo Pharmaceuticals, Inc. is recalling 8,139 cartons of Clonazepam Orally Disintegrating Tablets, USP (C-IV) from Lot 550147301 due to labeling errors on the cartons. The cartons are labeled as containing 0.125 mg tablets; however, the actual tablets inside the blister strips contain 0.25 mg.
The affected product has an expiration date of 08/31/2026 and was distributed nationwide in the USA and Puerto Rico by Par Pharmaceutical. This labeling discrepancy could lead to medication errors if healthcare providers or patients use the incorrect carton label to determine dosing.
The recalled product
- Product
- CLONAZEPAM (CLONAZEPAM)
- Brand
- CLONAZEPAM
- Manufacturer
- Endo Pharmaceuticals, Inc.
- Category
- Drug
- Hazard
- mis-labeling
- incorrect-strength
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 550147301
- Exp. 08/31/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CLONAZEPAM
- SevereClonazepam Tablets Recalled Due to Incorrect Carton Labeling
FDA (Drugs) · 2025-01-15
- CriticalClonazepam Orally Disintegrating Tablets Carton Mislabeled on Declared Strength
FDA (Drugs) · 2025-01-15
- SevereClonazepam Tablets Recalled Due to Carton Labeling Error
FDA (Drugs) · 2025-01-15
- SevereClonazepam tablets recalled for incorrect carton labeling
FDA (Drugs) · 2025-01-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27